Renaissance Group’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-15,147
| Closed | -$987K | – | 284 |
|
|
2021
Q1 | $987K | Buy |
15,147
+474
| +3% | +$30.9K | 0.04% | 168 |
|
|
2020
Q4 | $965K | Sell |
14,673
-557
| -4% | -$32.8K | 0.04% | 158 |
|
|
2020
Q3 | $787K | Sell |
15,230
-122
| -0.8% | -$6.26K | 0.04% | 148 |
|
|
2020
Q2 | $756K | Sell |
15,352
-109
| -0.7% | -$5.88K | 0.04% | 152 |
|
|
2020
Q1 | $788K | Buy |
15,461
+1,530
| +11% | +$88.2K | 0.04% | 124 |
|
|
2019
Q4 | $768K | Buy |
13,931
+2,445
| +21% | +$133K | 0.03% | 172 |
|
|
2019
Q3 | $578K | Buy |
11,486
+241
| +2% | +$12.1K | 0.02% | 180 |
|
|
2019
Q2 | $567K | Sell |
11,245
-136
| -1% | -$6.6K | 0.02% | 185 |
|
|
2019
Q1 | $529K | Sell |
11,381
-726
| -6% | -$36.8K | 0.02% | 198 |
|
|
2018
Q4 | $594K | Buy |
12,107
+385
| +3% | +$21.9K | 0.03% | 167 |
|
|
2018
Q3 | $727K | Buy |
11,722
+469
| +4% | +$28.5K | 0.03% | 172 |
|
|
2018
Q2 | $606K | Buy |
11,253
+631
| +6% | +$31.5K | 0.02% | 180 |
|
|
2018
Q1 | $483K | Buy |
10,622
+235
| +2% | +$10.1K | 0.02% | 193 |
|
|
2017
Q4 | $408K | Sell |
10,387
-31
| -0.3% | -$1.18K | 0.01% | 223 |
|
|
2017
Q3 | $384K | Hold |
10,418
| – | – | 0.01% | 224 |
|
|
2017
Q2 | $401K | Buy |
10,418
+191
| +2% | +$6.99K | 0.01% | 192 |
|
|
2017
Q1 | $348K | Buy |
10,227
+671
| +7% | +$22K | 0.01% | 212 |
|
|
2016
Q4 | $314K | Buy |
9,556
+102
| +1% | +$3.31K | 0.01% | 239 |
|
|
2016
Q3 | $305K | Sell |
9,454
-225
| -2% | -$7.29K | 0.01% | 219 |
|
|
2016
Q2 | $299K | Buy |
9,679
+199
| +2% | +$6.22K | 0.01% | 207 |
|
|
2016
Q1 | $284K | Sell |
9,480
-257
| -3% | -$7.1K | 0.01% | 221 |
|
|
2015
Q4 | $270K | Sell |
9,737
-162
| -2% | -$4.61K | 0.01% | 237 |
|
|
2015
Q3 | $302K | Buy |
9,899
+45
| +0.5% | +$1.57K | 0.01% | 201 |
|
|
2015
Q2 | $361K | Buy |
9,854
+248
| +3% | +$8.84K | 0.01% | 170 |
|
|
2015
Q1 | $339K | Buy |
9,606
+121
| +1% | +$4.14K | 0.01% | 178 |
|
|
2014
Q4 | $290K | Sell |
9,485
-29
| -0.3% | -$904 | 0.01% | 193 |
|
|
2014
Q3 | $279K | Buy |
9,514
+81
| +0.9% | +$2.47K | 0.01% | 178 |
|
|
2014
Q2 | $269K | Sell |
9,433
-198
| -2% | -$5.52K | 0.01% | 213 |
|
|
2014
Q1 | $275K | Buy |
9,631
+669
| +7% | +$17.4K | 0.01% | 176 |
|
|
2013
Q4 | $238K | Buy |
+8,962
| New | +$249K | 0.01% | 198 |
|
Other funds holding EHC
JP
Renaissance Group's EHC Position: Q2 2021 in Review
Renaissance Group sold out of Encompass Health (EHC) in Q2 2021, closing a stake of 15,147 shares — an estimated $987K sold.
Renaissance Group first reported a position in EHC in Q4 2013 and held it in 30 quarters. The position peaked at $987K in Q1 2021. 414 funds tracked by Wall St. Rank hold EHC as of Q2 2021.
- Renaissance Group reported no remaining Encompass Health position as of Q2 2021 after selling out during the quarter.
- Renaissance Group sold 15,147 Encompass Health shares in Q2 2021, an estimated $987K.
- Renaissance Group first reported a position in Encompass Health in Q4 2013 and held it in 30 quarters.
- Renaissance Group's Encompass Health position peaked at $987K in Q1 2021.
- 414 funds tracked by Wall St. Rank held Encompass Health as of Q2 2021.
Based on Renaissance Group's 13F filing for Q2 2021, filed 13 Aug 2021.